BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 17287896)

  • 1. Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in Thais.
    Yamada S; Matsuhisa T; Makonkawkeyoon L; Chaidatch S; Kato S; Matsukura N
    J Gastroenterol; 2006 Dec; 41(12):1169-77. PubMed ID: 17287896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominant mucosal IL-8 mRNA expression in non-cagA Thais is risk for gastric cancer.
    Yamada S; Kato S; Matsuhisa T; Makonkawkeyoon L; Yoshida M; Chakrabandhu T; Lertprasertsuk N; Suttharat P; Chakrabandhu B; Nishiumi S; Chongraksut W; Azuma T
    World J Gastroenterol; 2013 May; 19(19):2941-9. PubMed ID: 23704827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-parietal cell antibody and serum pepsinogen assessment in screening for gastric carcinoma.
    Sugiu K; Kamada T; Ito M; Kaya S; Tanaka A; Kusunoki H; Hata J; Haruma K
    Dig Liver Dis; 2006 May; 38(5):303-7. PubMed ID: 16549394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of atrophic gastritis with Helicobacter pylori-CagA(+) and interleukin-1 gene polymorphisms.
    Sierra R; Une C; Ramirez V; Alpizar-Alpizar W; Gonzalez MI; Ramirez JA; De Mascarel A; Cuenca P; Perez-Perez G; Megraud F
    World J Gastroenterol; 2008 Nov; 14(42):6481-7. PubMed ID: 19030199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylori infection: a prospective study.
    So JB; Yeoh KG; Moochala S; Chachlani N; Ho J; Wong WK; Mack P; Goh PM
    Gastric Cancer; 2002; 5(4):228-32. PubMed ID: 12491081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori and Schistosoma japonicum co-infection in a Chinese population: helminth infection alters humoral responses to H. pylori and serum pepsinogen I/II ratio.
    Du Y; Agnew A; Ye XP; Robinson PA; Forman D; Crabtree JE
    Microbes Infect; 2006 Jan; 8(1):52-60. PubMed ID: 16260169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of the cancer related gene and Helicobacter pylori infection in Japanese gastric cancer patients. An age and gender matched case-control study.
    Kato S; Onda M; Matsukura N; Tokunaga A; Matsuda N; Yamashita K; Shields PG
    Cancer; 1996 Apr; 77(8 Suppl):1654-61. PubMed ID: 8608558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum gastrin level and pepsinogen I/II ratio as biomarker of Helicobacter pylori chronic gastritis.
    Arinton IG
    Acta Med Indones; 2010 Jul; 42(3):142-6. PubMed ID: 20724767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels.
    Yanaoka K; Oka M; Yoshimura N; Mukoubayashi C; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Yamamichi N; Fujishiro M; Takeshita T; Mohara O; Ichinose M
    Int J Cancer; 2008 Aug; 123(4):917-26. PubMed ID: 18508314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum pepsinogen I and pepsinogen I/II ratio and Helicobacter pylori infection are associated with increased risk of gastric cancer: 14-year follow up result in a rural Chinese community.
    Zhang X; Xue L; Xing L; Wang J; Cui J; Mi J; Xing X; Wang J; Du Z; Misumi J; Tian Q; Wang L
    Int J Cancer; 2012 Apr; 130(7):1614-9. PubMed ID: 21547904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese.
    Goto Y; Ando T; Yamamoto K; Tamakoshi A; El-Omar E; Goto H; Hamajima N
    Int J Cancer; 2006 Jan; 118(1):203-8. PubMed ID: 16032704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1beta and IL-8, matrix metalloproteinase 3, and pepsinogen secretion before and after H. pylori eradication in gastroduodenal phenotypes.
    Chang YW; Oh HC; Jang JY; Hwangbo Y; Lee JW; Lee HJ; Joo KR; Dong SH; Kim SS; Kim HJ; Kim BH; Chang R
    Scand J Gastroenterol; 2008; 43(10):1184-93. PubMed ID: 18609140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between pepsinogen I/II ratio and age or upper gastrointestinal diseases in Helicobacter pylori-positive and -negative subjects].
    Paik CN; Chung IS; Nam KW; Kwon JH; Chang JH; Suh JP; Park JM; Cho YK; Lee IS; Kim SW; Choi MG
    Korean J Gastroenterol; 2007 Aug; 50(2):84-91. PubMed ID: 17928751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K; Yoshihara M; Ito M; Haruma K; Tanaka S; Chayama K
    J Gastroenterol; 2003; 38(4):332-8. PubMed ID: 12743772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influences of Helicobacter pylori on serum pepsinogen concentrations in dialysis patients.
    Tamura H; Tokushima H; Murakawa M; Matsumura O; Itoyama S; Mitarai T; Isoda K
    Nephrol Dial Transplant; 1999 Jan; 14(1):113-7. PubMed ID: 10052488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.